Egypt: Memphis Pharma studies $6.1mln machinery purchase, clarifies position on land plot

In the first half (H1) of fiscal year (FY) 2025/2026, Memphis Pharmaceutical achieved 5% year-on-year (YoY) higher net profits

Staff Writer, Arab Finance

February 4, 2026

PHOTO

Arab Finance: Memphis Pharmaceutical and Chemical Industries is currently reviewing technical and financial offers for the purchase of new machinery and production lines for ampoules and ointment, with an investment cost of EGP 288 million, according to a statement.

This comes as a response to the circulated news regarding the sale of a 2,426-square-meter plot of land owned by the company.

In the first half (H1) of fiscal year (FY) 2025/2026, Memphis Pharmaceutical achieved 5% year-on-year (YoY) higher net profits after tax at EGP 281.778 million, compared to EGP 268.080 million.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO